ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,399, issued on April 21, was assigned to TRANSLATE BIO INC. (Waltham, Mass.).
"Compositions for CFTR MRNA therapy" was invented by Anusha Dias (Cambridge, Mass.), Khang Anh Tran (Cambridge, Mass.), Lianne Boeglin (Cambridge, Mass.), Frank Derosa (Cambridge, Mass.), John Androsavich (Cambridge, Mass.), Shraddha Sharma (Cambridge, Mass.), Gang Sun (Cambridge, Mass.), Neha Kaushal (Cambridge, Mass.) and Shrirang Karve (Cambridge, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides, among other things, improved methods and pharmaceutical compositions for treating cystic fibrosis based on codon optimized mRNA encoding a w...